Key Laboratory of Combinatorial Biosynthesis and Drug Discovery Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Department of Neurosurgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Med Res Rev. 2019 Nov;39(6):2286-2313. doi: 10.1002/med.21584. Epub 2019 Apr 17.
Ongoing studies have determined that the gut microbiota is a major factor influencing both health and disease. Host genetic factors and environmental factors contribute to differences in gut microbiota composition and function. Intestinal dysbiosis is a cause or a contributory cause for diseases in multiple body systems, ranging from the digestive system to the immune, cardiovascular, respiratory, and even nervous system. Investigation of pathogenesis has identified specific species or strains, bacterial genes, and metabolites that play roles in certain diseases and represent potential drug targets. As research progresses, gut microbiome-based diagnosis and therapy are proposed and applied, which might lead to considerable progress in precision medicine. We further discuss the limitations of current studies and potential solutions.
正在进行的研究已经确定,肠道微生物群是影响健康和疾病的主要因素。宿主遗传因素和环境因素导致肠道微生物群组成和功能的差异。肠道菌群失调是多种身体系统疾病的原因或促成因素,范围从消化系统到免疫系统、心血管系统、呼吸系统,甚至神经系统。发病机制的研究已经确定了在某些疾病中起作用的特定物种或菌株、细菌基因和代谢物,它们代表了潜在的药物靶点。随着研究的进展,基于肠道微生物组的诊断和治疗被提出并应用,这可能会推动精准医学取得重大进展。我们进一步讨论了当前研究的局限性和潜在的解决方案。